Last reviewed · How we verify

NCT06136637: MOGLYCC

Monitoring of Glycocalyx for Prediction of Complications After Cardiac Surgery

Recruiting now Last updated 18 July 2024
What this trial tests

trial in Cardiac Surgery in 77 participants. Currently enrolling.

Timeline
1 June 2022
Primary endpoint
1 July 2026
1 July 2026

Quick facts

Lead sponsorUniversity Hospital, Rouen
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment77
Start date1 June 2022
Primary completion1 July 2026
Estimated completion1 July 2026
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Rouen

Who can join

Adults 18 to 80, any sex, with Cardiac Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective observational study of the evolution of the microcirculation and the sublingual glycocalyx in perioperative cardiac surgery under cardiopulmonary bypass. Our main objective is to evaluate the prognostic value of the variation of the thickness of the perioperative glycocalyx for the occurrence of a major complication in the first 24 hours after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Surgery

Currently open trials in the same condition.

Other University Hospital, Rouen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06136637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing